Search Results

Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products to researchers developing liquid biopsy applications on the Agena MassARRAY platform.

Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that it has completed the previously announced acquisition of Agena Biosciences, Inc.

Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.

Agena Bioscience®, a global provider of genetic testing solutions, announced a partnership with Manchester University to expand awareness and access to PGx educational resources.

Mesa Laboratories, Inc., a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. for a cash purchase price of $300 million, subject to customary purchase price adjustments.